Projects per year
Personal profile
Education
- 2008 國立台灣大學生化科學所博士
- 2001 國立成功大學生物系學士
Experience
- 2022- 臺北醫學大學CRISPR核心實驗室主任
- 2019-2022 臺北醫學大學CRISPR核心實驗室代理主任
- 2017- 臺北醫學大學癌症轉譯研究中心專案助理研究員
Fingerprint
Dive into the research topics where Cheng-Ying Chu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Immune-Modulation of Nk Cells in Kidney Disease: Enhancing Therapeutic Performance by Crispr Gene Editing( I )
Chu, C.-Y. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Crispr Screen Identifies Sting1 as a Target to Overcome Olaparib Resistance( I )
Chu, C.-Y. (PI)
7/1/25 → 6/30/26
Project: A - Government Institution › b - National Science and Technology Council
-
Crispr Screen Identifies Sting1 as a Target to Overcome Olaparib Resistance( I )
Chu, C.-Y. (PI)
7/1/24 → 6/30/25
Project: A - Government Institution › b - National Science and Technology Council
-
Crispr Screen Identifies Sting1 as a Target to Overcome Olaparib Resistance( I )
Chu, C.-Y. (PI)
7/1/23 → 6/30/24
Project: A - Government Institution › b - National Science and Technology Council
-
新聘教師研究補助
Chu, C.-Y. (PI)
12/20/22 → 12/19/23
Project: B - Project of TMU › g - Research Grants for Newly Hired Faculty
-
Plasmon-activated water reduces amyloid-β42 aggregation and exhibits neuroprotective potential in Alzheimer’s disease
Chiang, C. I., Liu, C. C., Hao, P. J., Chou, C. M., Chu, C. Y., Liu, E. H., Liu, C. Y., Lee, Y. L. A., Hu, C. J., Liu, Y. C. & Cheng, C. H., Apr 2026, In: Journal of the Taiwan Institute of Chemical Engineers. 181, 106507.Research output: Contribution to journal › Article › peer-review
-
Correction to: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients (Biomarker Research, (2025), 13, 1, (7), 10.1186/s40364-024-00715-5)
Cheng, T. C., Hung, M. C., Wang, L. H., Tu, S.-H., Wu, C.-H., Yen, Y., Chen, C. L., Whang-Peng, J., Lee, W. J., Liao, Y. C., Lee, Y.-C., Pan, M. H., Lin, H. K., Tzeng, H.-E., Guo, P., Chu, C.-Y., Chen, L. C. & Ho, Y.-S., Dec 2025, In: Biomarker Research. 13, 1, 100.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
FGFR inhibitors promote the autophagic degradation of IFN-γ-induced PD-L1 and alleviate the PD-L1-mediated transcriptional suppression of FGFR3-TACC3 in non-muscle-invasive bladder cancer
Lin, Y. C., Chu, C. Y., Hsieh, T. H., Lin, B. J., Liou, J. P., Yen, Y. & Chen, C. H., Dec 2025, In: Cell Death and Disease. 16, 1, 485.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients
Cheng, T.-C., Hung, M.-C., Wang, L.-H., Tu, S.-H., Wu, C.-H., Yen, Y., Chen, C.-L., Whang-Peng, J., Lee, W.-J., Liao, Y.-C., Lee, Y.-C., Pan, M.-H., Lin, H.-K., Tzeng, H.-E., Guo, P., Chu, C.-Y. & Chen, L.-C., Jan 9 2025, In: Biomarker Research. 13, 1, p. 7 7.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
IL-19 as a promising theranostic target to reprogram the glioblastoma immunosuppressive microenvironment
Lee, G. A., Hsu, J. B. K., Chang, Y. W., Hsieh, L. C., Li, Y. T., Wu, Y. C., Chu, C. Y., Chiang, Y. H., Guo, W. Y., Wu, C. C., Chen, L. W., Kao, H. W., Lin, W. L., Tseng, L., Weng, T. W., Kuo, D. P., Cheng, S. J., Chen, Y. C., Huang, S. W. & Kung, H. J. & 1 others, , Mar 8 2025, In: Journal of Biomedical Science. 32, 1, p. 34 34.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus)
Datasets
-
Additional file 1: Figure S1. of Thrombospondin-2 promotes prostate cancer bone metastasis by the up-regulation of matrix metalloproteinase-2 through down-regulating miR-376c expression
Chu, C.-Y. (Creator), Chen, P.-C. (Contributor), Lin, L.-W. (Creator), Huang, Y.-L. (Creator), Lin, T.-H. (Creator), Tsai, C.-H. (Creator) & Tang, C.-H. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3674824_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3674824_d1.v1
Dataset
-
Thrombospondin-2 promotes prostate cancer bone metastasis by the up-regulation of matrix metalloproteinase-2 through down-regulating miR-376c expression
Chen, P.-C. (Contributor), Tang, C.-H. (Contributor), Lin, L.-W. (Creator), Tsai, C.-H. (Creator), Chu, C.-Y. (Creator), Lin, T.-H. (Creator) & Huang, Y.-L. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3674824.v1, https://figshare.com/collections/Thrombospondin-2_promotes_prostate_cancer_bone_metastasis_by_the_up-regulation_of_matrix_metalloproteinase-2_through_down-regulating_miR-376c_expression/3674824/1
Dataset